Cardiovasc Prev Pharmacother > v.6(3)

2 results

85 Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks
Terry Gbaa, John Bolodeoku
KMSID: 1516088129   Cardiovasc Prev Pharmacother. 2024;6(3):85-91.   Published online 2024 July 30    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e11
      
92 Health behaviors, knowledge, and attitudes toward cardiovascular disease risk factors in young Iraqi adults: a sample from Erbil, Iraq
Halmat Ahmed Sulaiman, Isil Isik Andsoy
KMSID: 1516088130   Cardiovasc Prev Pharmacother. 2024;6(3):92-101.   Published online 2024 July 30    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e12
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap